Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers

Prostate cancer (PCa) is second only to lung cancer as a cause of death. Clinical assessment of patients and treatment efficiency therefore depend on the disease being diagnosed as early as possible. However, due to issues regarding the use of prostate-specific antigen (PSA) for screening purposes,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Wei, Fei, Xiang, Wang, Xia, Song, Yan, Chen, Fangjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218965/
https://www.ncbi.nlm.nih.gov/pubmed/32454797
http://dx.doi.org/10.1155/2020/8730608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218965/
https://www.ncbi.nlm.nih.gov/pubmed/32454797
http://dx.doi.org/10.1155/2020/8730608

Ejemplares similares